SCHEMBL480271

SCHEMBL480271

CCOc1cncc(-c2ccc(C(C)(c3ccc(-c4ccc(C(F)(F)F)nn4)cn3)C(C)C)cc2)c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5AP P20292 3/20 0.68
CYP11B1 P15538 3/20 0.38
CYP11B2 P19099 3/20 0.38
CHRNB1 P11230 1/20 0.38
CHRNB2 P17787 1/20 0.38
CHRNB4 P30926 1/20 0.38
CHRNA3 P32297 1/20 0.38
CHRNB3 Q05901 1/20 0.38
CTPS1 P17812 3/20 0.35
PRMT5 O14744 1/20 0.34
WDR77 Q9BQA1 1/20 0.34
PTGS2 P35354 2/20 0.34
PTGS1 P23219 1/20 0.34
TRPV3 Q8NET8 2/20 0.33
AKT1 P31749 2/20 0.33
RXRA P19793 1/20 0.33
RXRB P28702 1/20 0.33
RXRG P48443 1/20 0.33
PIK3CG P48736 1/20 0.33
CCR2 P41597 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL480192 0.93 ALOX5AP (0.68) ALOX5APCYP11B1CYP11B2CHRNB1CHRNB2
SCHEMBL480477 0.91 ALOX5AP (0.66) ALOX5APCYP11B1CYP11B2CHRNB1CHRNB2
SCHEMBL480262 0.90 ALOX5AP (0.82) ALOX5APCYP11B1CYP11B2CHRNB1CHRNB2
SCHEMBL480245 0.89 ALOX5AP (0.68) ALOX5APCYP11B1CYP11B2CHRNB1CHRNB2
SCHEMBL480189 0.88 ALOX5AP (0.63) ALOX5APCHRNB1CHRNB2CHRNB4CHRNA3
SCHEMBL9924164 0.87 ALOX5AP (0.76) ALOX5APCYP11B1CYP11B2CHRNB1CHRNB2
SCHEMBL480206 0.84 ALOX5AP (0.64) ALOX5APTRPV3
SCHEMBL480275 0.81 ALOX5AP (1.00) ALOX5APCYP11B1CYP11B2CTPS1
SCHEMBL480286 0.81 ALOX5AP (1.00) ALOX5APCYP11B1CYP11B2CTPS1
SCHEMBL480265 0.80 ALOX5AP (0.80) ALOX5APCYP11B1CYP11B2CTPS1PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8440672-B2 Diphenyl substituted alkanes MERCK SHARP & DOHME CORP. (US) 2013-05-14 US claimed
EP-2064204-B1 INHIBITORS OF 5 -LIPOXYGENASE ACTIVATING PROTEIN ( FLAP) MERCK SHARP & DOHME (US) 2012-02-01 EP claimed
US-20100168076-A1 DIPHENYL SUBSTITUTED ALKANES MERCK SHARP & DOHME CORP. 2010-07-01 US claimed
US-8440672-B2 Diphenyl substituted alkanes MERCK SHARP & DOHME CORP. (US) 2013-05-14 US disclosed
EP-2064204-B1 INHIBITORS OF 5 -LIPOXYGENASE ACTIVATING PROTEIN ( FLAP) MERCK SHARP & DOHME (US) 2012-02-01 EP disclosed
US-20100168076-A1 DIPHENYL SUBSTITUTED ALKANES MERCK SHARP & DOHME CORP. 2010-07-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100168076-A1 DIPHENYL SUBSTITUTED ALKANES ALOX5, ALOX15, ALOX15B ALOX5AP 14/4885CYP11B1 251/4885CYP11B2 294/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.